Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Terns Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/10/2023 |
SC 13G/A
| FIL Ltd reports a 8.4% stake in TERNS PHARMACEUTICALS INC |
| 10/04/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Terns Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners III, L.P. reports a 7.7% stake in Terns Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 9.9% stake in Terns Pharmaceuticals, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 14.9% stake in TERNS PHARMACEUTICALS INC |
| 02/08/2023 |
SC 13G/A
| BML Investment Partners, L.P. reports a 0% stake in Terns Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| BML Investment Partners, L.P. reports a 0% stake in Terns Pharmaceuticals, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/29/2022 |
SC 13G/A
| LAV Biosciences Fund V, L.P. reports a 6.2% stake in Terns Pharmaceuticals, Inc. |
| 08/16/2022 |
SC 13G/A
| Flynn James E reports a 4.9% stake in Terns Pharmaceuticals, Inc. |
| 06/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G/A
| FMR LLC reports a 11.1% stake in TERNS PHARMACEUTICALS INC |
|
|